Epstein-Barr virus (EBV) expresses two immediate-early proteins, Rta and Zta, which are key transcription factors that can form a complex with MCAF1 at Zta-responsive elements (ZREs) to synergistically activate several viral lytic genes. Our previous research indicated that RanBPM interacts with Rta and enhances Rta sumoylation. Here we showed that RanBPM binds to Zta in vitro and in vivo, and acts as an intermediary protein in Rta-Zta complex formation. The RtaRanBPM-Zta complex was observed to bind with ZREs in the transcriptional activation of key viral genes, such as BHLF1 and BHRF1, while the introduction of RanBPM short hairpin RNA (shRNA) subsequently reduced the synergistic activity of Zta and Rta. RanBPM was found to enhance Zta-dependent transcriptional activity via the inhibition of Zta sumoylation. Interestingly, Z-K12R, a sumoylation-defective mutant of Zta, demonstrated transcriptional activation capabilities that were stronger than those of Zta and apparently unaffected by RanBPM modulation. Finally, RanBPM silencing inhibited the expression of lytic proteins. Taken together, these results shed light on the mechanisms by which RanBPM regulates Zta-mediated transcriptional activation, and point to an important role for RanBPM in EBV lytic progression.
INTRODUCTION
Epstein-Barr virus (EBV) is an oncovirus of the human herpesvirus family that is associated with many tumour diseases (Henle et al., 1970; Jones et al., 1988; Su et al., 1991; Wolf et al., 1973; Wu et al., 2000) . During the switch from latency to the lytic cycle, EBV first expresses two immediate-early transcription factors, Rta and Zta, respectively encoded by BRLF1 and BZLF1. Rta and Zta regulate the expression of key EBV lytic genes (Chang et al., 2010; Chevallier-Greco et al., 1986; Giot et al., 1991; HolleyGuthrie et al., 1990; Kenney et al., 1989; Ye et al., 2007 Ye et al., , 2010 . Zta, a member of the bZip family (Farrell et al., 1989; Kouzarides et al., 1991) , binds with Zta-responsive elements (ZREs) to activate the transcription of viral genes that are essential for lytic replication (Fixman et al., 1992) and also associates with TBP, TFIID and CBP to form a stable transcription initiation complex (Lieberman, 1994; Lieberman & Berk, 1991; Chen et al., 2001) . Moreover, Zta binds with ZREs in the BZLF1 promoter (Zp) to autoregulate its own transcription (Flemington & Speck, 1990; Liu & Speck, 2003) , which is critical for immortalization of primary B-cells by EBV (Yu et al., 2012) . Post-translational modification by SUMO-1, SUMO-2 and SUMO-3 at lysine 12 suppresses Zta-mediated transactivation activity, while SENP-1 has been shown to deconjugate SUMO-Zta (Adamson, 2005; Hagemeier et al., 2010; Murata et al., 2010) . The transcriptional repression of Zta via sumoylation was found to be associated with histone deacetylase 3 (HDAC3) and EBV-encoded protein kinase (EBV-PK) (Hagemeier et al., 2010; Murata et al., 2010) .
After binding to Rta-responsive elements (RREs), Rta activates viral lytic genes (Chevallier-Greco et al., 1989; Heilmann et al., 2012; Kenney et al., 1989; Quinlivan et al., 1993) , and is known to form a complex with Sp1 through MCAF1 to autoregulate the BRLF1 promoter (Rp) and enhance Sp1-dependent transcription (Chang et al., 2005) . Moreover, Rta can activate phosphorylation of the p38, JNK and ERK signalling pathways (Adamson et al., 2000; Lee et al., 2008) to induce binding of an Rta-MCAF1-phosphorylated ATF2 protein complex with the ZII element in Zp, thus activating Zta expression (Adamson et al., 2000; Lin et al., 2014) . Zta is also known to activate BRLF1 transcription (Flemington & Speck, 1990; Liu & Speck, 2003) . We previously demonstrated that Rta activates both TATA and TATA-less transcription via TAF4 interactions . In addition, sumoylation by SUMO-1 has been shown to increase Rta transactivation activity (Chang et al., 2004) . It is also known that LF2 enhances Rta conjugation to SUMO-2 and SUMO-3 (Calderwood et al., 2008) , but this is unrelated to LF2-mediated repression of Rta functions (Heilmann et al., 2010) . However, we have found that SUMO-2-Rta can be ubiquitinated via RNF4, leading to decreased Rta stability during lytic progression .
RanBPM is a multifunctional protein with distinct domains, such as SPRY, LisH/CTLH and the CRA motif (Murrin & Talbot, 2007; Nishitani et al., 2001) . Known to interact with many transmembrane receptors, including p75NTR, tropomyosin-related kinase A (TrkA), TrKB, Met and integrin LFA-1 (Bai et al., 2003; Denti et al., 2004; Wang et al., 2002; Yin et al., 2010; Yuan et al., 2006) , to regulate downstream signalling pathways, RanBPM also enhances the transcriptional activities of the androgen receptor, the glucocorticoid receptor and the thyroid hormone receptor (Poirier et al., 2006; Rao et al., 2002) , and can increase transcriptional and post-translational p73a levels to regulate cell death (Kramer et al., 2005; Liu et al., 2013) . RanBPM is known to be regulated by proteasome-dependent degradation, with USP11 found to inhibit RanBPM ubiquitination (Ideguchi et al., 2002) . Previously, we showed that RanBPM interacts with Rta to promote Rta sumoylation and enhance EBV lytic progression . Here we show that RanBPM interacts with Zta, and reduces Zta sumoylation to increase Zta-regulated transcriptional activity, thereby facilitating lytic progression. RanBPM was also found to form a complex with Rta and Zta that upregulated Rta-Zta synergistic activation of viral genes, further contributing to EBV lytic activation.
RESULTS

Interaction between Zta and RanBPM
We previously demonstrated that RanBPM binds to Rta and enhances Rta sumoylation ) and thus we sought to examine possible interactions between Zta and RanBPM, using GST-RanBPM fusion protein expressed in Escherichia coli in a glutathione S-transferase (GST) pull-down assay. GST or GST-RanBPM bound to glutathione-Sepharose beads were added to the lysates of 293T cells transfected with pFlag-Zta. Proteins bound to the beads were washed and eluted, then analysed by immunoblotting (IB) with anti-Zta antibody. Results indicated that Flag-Zta expressed in 293T cells (Fig. 1a, lane 1) was retained by GST-RanBPM beads, but not GST beads (Fig. 1a, lanes 2 and 3) . A similar assay was performed by adding GST or GST-RanBPM beads to E. coli BL21(DE3) (pET-Zta) lysates. Results showed that His-Zta expressed by E. coli (Fig. 1a, lane 4) was retained by GST-RanBPM beads, but not by GST beads (Fig. 1a , lanes 5 and 6), indicative of a direct interaction between Zta and RanBPM. An immunoprecipitation assay was performed in 293T cells cotransfected with pFlag-Zta and pFlag-RanBPM. Immunoblot analysis revealed that endogenous RanBPM in cell lysates (Fig. 1b, lane 1) was immunoprecipitated by anti-RanBPM antibody (Fig. 1b, lane 4) and coimmunoprecipitated with Zta by anti-Zta (Fig. 1b, lane 3) . Additionally, Flag-tagged Zta (Fig. 1b, lane 5) was immunoprecipitated by anti-Zta (Fig. 1b, lane 8) and coimmunoprecipitated with RanBPM using anti-RanBPM (Fig. 1b, lane 7) . However, anti-IgG antibody did not immunoprecipitate either RanBPM or Zta (Fig.  1b , lanes 2 and 6). To confirm specific binding between Zta and RanBPM, 293T cells were cotransfected with pFlagRanBPM and an empty vector, pTag-2A. Immunoblot analysis revealed that RanBPM in lysates (Fig. 1b, lane 9) was immunoprecipitated by anti-RanBPM (Fig. 1b, lane 12) , but not coimmunoprecipitated by anti-Zta (Fig. 1b, lane  11) or anti-IgG (Fig. 1b, lane 10) . A parallel experiment found that Zta from P3HR1 cells treated with sodium butyrate and 12-O-tetradecanoylphobol-13-acetate (TPA) to induce the EBV lytic cycle (Fig. 1c, lane 5 ) was immunoprecipitated by anti-Zta (Fig. 1c, lane 8) and coimmunoprecipitated with RanBPM by anti-RanBPM (Fig. 1c, lane 7) . Moreover, RanBPM in P3HR1 lysates (Fig. 1c , lane 1) was immunoprecipitated by anti-RanBPM (Fig. 1c , lane 4) and coimmunoprecipitated with Zta using anti-Zta (Fig. 1c , lane 3). However, anti-IgG did not immunoprecipitate either Zta or RanBPM (Fig. 1c , lanes 2 and 6). These results demonstrate that a specific binding interaction takes place between Zta and RanBPM during EBV lytic activation.
Mapping the binding domains in Zta and RanBPM
To identify the Zta-interacting regions in RanBPM, plasmids expressing Flag-Zta and different lengths of RanBPM fused to GFP (Fig. 2a) were cotransfected into 293T cells. An empty GFP expression vector, pEGFP-C1, was used as a negative control. Immunoblot analysis revealed that Zta in cell lysates (Fig. 2b, lane 6 ) was immunoprecipitated by anti-Zta (Fig. 2b, lanes 7-11) . Moreover, GFP-tagged RanBPM (GFP-RanBPM), GFP-RanBPM-209 (GFP fused to the aa 209-729 region of RanBPM) and GFP-SPRY (GFP fused to the RanBPM SPRY domain) were coimmunoprecipitated with Zta by anti-Zta (Fig. 2b,  lanes 2-4) . However, GFP alone, or a GFP fusion protein containing the same RanBPM segment as GFP-RanBPM-209, but lacking the SPRY domain (GFP-RanBPM-334), were not coimmunoprecipitated with Zta (Fig. 2b , lanes 1 and 5), suggesting that the RanBPM SPRY domain is key to interaction. Plasmids encoding GFP-Zta, GFP-ZN, GFP-ZM or GFP-ZC (Fig. 2c) were cotransfected with Flag-RanBPM into 293T cells in a parallel study. FlagRanBPM in cell lysates (Fig. 2d, lane 6 ) was immunoprecipitated by anti-Flag antibody (Fig. 2d, lanes 7-11) . GFP fusion proteins coimmunoprecipitated with Flag-RanBPM using anti-Flag were subsequently detected with anti-GFP antibody (Fig. 2d) , and results showed that RanBPM interacted with GFP-Zta and GFP-ZC (Fig. 2d , lanes 2 and 5), but not with GFP-ZN and GFP-ZM (Fig. 2d, lanes 3 and  4) , indicating that the aa 194-245 region in Zta is the region of interaction with RanBPM. 
Enhancement of Zta transactivation activity by RanBPM
A transient reporter assay was performed to examine the influence of RanBPM on the transcriptional activation of Zta. Two reporter plasmids containing ZRE sequences, pRp-ZRE or pBHLF1, were independently cotransfected with either pCMV-Z alone or pCMV-Z and pEGFPRanBPM into BJAB cells. Results showed that cotransfection with pCMV-Z activated luc transcription in pRp-ZRE and pBHLF1 up to 195-fold and 24-fold over baseline, respectively (Fig. 3a, b) . However, cotransfection with both pCMV-Z and pEGFP-RanBPM respectively increased pRp-ZRE and PBHLF1 promoter activity by 405-fold and 48-fold over baseline (Fig. 3a, b) , indicating that RanBPM strongly enhances the transactivation activity of Zta. Interestingly, overexpression of RanBPM did not change Zta protein levels (Fig. 3d, lanes 3 and 5) . When using pRRE (which contains an RRE from the BMRF1 promoter) as a reporter plasmid, cotransfection with pCMV-R increased promoter activity up to 11-fold over baseline (Fig. 3c) . However, cotransfecting pCMV-Z and pEGFP-RanBPM did not affect promoter activity (Fig. 3c ), thereby confirming that RanBPM enhances Zta-dependent transcription via ZREs.
RanBPM mediates Rta and Zta interaction
We previously showed that Rta and RanBPM interact directly , and this study further confirmed that RanBPM binds to Zta ( Fig. 1 ), suggesting that RanBPM may be involved in Rta and Zta interaction. Binding domain analysis revealed that the SPRY domain in RanBPM binds to both Rta and Zta (Fig. 2) . To confirm this, in vitro immunoprecipitation using the E. coli-expressed fusion proteins His-Rta ( The Rta -RanBPM -Zta complex binds to ZREs Rta and Zta can form a complex that synergistically activates key viral promoters (Chang et al., 2010) , and we therefore wished to determine if Rta, RanBPM and Zta also form a complex capable of binding to ZREs. A biotinylated ZRE probe ( Fig. 5a ) containing nucleotides 274 to 241 in the BHLF1 promoter was added to lysate prepared from induced P3HR1 cells. Proteins binding to the probe were then captured with streptavidin magnetic beads, and immunoblots revealed that Zta, RanBPM, and Rta bound with the ZRE probe, but did not bind with a mutant mZRE probe (Fig. 5a ). A chromatin immunoprecipitation (ChIP) assay using induced P3HR1 cells further confirmed these results. After cross-linked protein-DNA complexes were immunoprecipitated with anti-Zta, anti-RanBPM and anti- Rta antibodies, quantitative (q)PCR was performed with primers that were complementary to the flanking sequences of the ZRE region in the BHLF1 promoter. Results revealed that DNA fragments containing the BHLF1 promoter were immunoprecipitated (Fig. 5b) , and the amounts captured by anti-Zta, anti-RanBPM and anti-Rta exceeded those from reactions with either no antibody added or with antiIgG as a negative control (Fig. 5b) . A similar result was also found for the BHRF1 promoter (Fig. 5b) . However, qPCR showed that the amount of BMLF1 promoter DNA immunoprecipitated by anti-Rta was significantly higher than that immunoprecipitated by anti-Zta and antiRanBPM (Fig. 5b) ; Zta and RanBPM did not appear to bind to the ZRE in the BMLF1 promoter. Additionally, the amounts captured by anti-RanBPM antibody were much lower than those captured by anti-Zta or anti-Rta in the BHLF1 and BHRF1 promoters (Fig. 5b) , which may be indicative of limitations in binding capacity for the antiRanBPM antibody.
Involvement of RanBPM in Rta and Zta synergistic activity
Considering that RanBPM forms a complex with Rta and Zta to bind with ZREs (Fig. 5) , it is possible that RanBPM may be involved in Rta-Zta synergistic activation of viral promoters containing ZRE sequences. We therefore cotransfected the reporter plasmid pBHLF1 (which contains four copies of ZREs) with pCMV-R, pCMV-Z or both, into 293T cells. In transfected cells expressing Zta or Rta, luciferase activities displayed by the reporter plasmid respectively increased 301-fold and 15-fold (Fig. 6a) . However, Zta-and Rta-mediated promoter activities respectively decreased by 23.3 % and 40 % if the reaction included RanBPM shRNA (Fig. 6e) , indicating that RanBPM affects the transactivation capabilities of Zta and Rta (Fig. 6a) . Importantly, luciferase activity increased 1573-fold over negative controls upon cotransfection of pCMV-R and pCMV-Z, while knockdown of RanBPM dramatically decreased promoter activity by 58.9 %, indicating that RanBPM is involved in Rta and Zta synergistic activity (Fig. 6a) . Similar results were obtained with the pRp-ZRE and pEAD promoters (Fig. 6b, c) , which are known to be synergistically activated by Zta and Rta (Chang et al., 2010) . The pRRE promoter served as a negative control (Fig. 6d) , as Rta and Zta do not synergistically activate it.
Suppression of Zta sumoylation by RanBPM
Zta transactivation activity is suppressed after sumoylation at lysine 12 by SUMO-1, SUMO-2 or SUMO-3, while the Z-K12R mutant possesses increased transactivation capability (Adamson, 2005; Adamson & Kenney, 2001; Hagemeier et al., 2010; Murata et al., 2010) . We sought to ascertain whether RanBPM affects Zta-mediated transcriptional activity by influencing Zta sumoylation. 293T cells were cotransfected with pFlag-Zta, pHA-SUMO-2 and pEGFP-RanBPM, and 48 h after transfection, Flag-tagged Zta in lysates (Fig. 7a, lanes 2-7) was immunoprecipitated using anti-Flag. Sumoylated Zta (SUMO-Zta) was subsequently detected by immunoblotting with anti-HA antibody, and results indicated that cotransfection with pFlag-Zta and pHA-SUMO-2 was necessary for the detection of SUMO-Zta (Fig. 7a, IP, lane 3) ; transfection with pFlag-Zta or pHA-SUMO-2 alone was insufficient (Fig. 7a, IP, lanes 1 and 2) . SUMO-Zta was not detected in Z-K12R mutant clones (Fig. 4a, IP, lane 7) . Interestingly, SUMO-Zta levels decreased when cells were cotransfected with plasmids expressing GFP-RanBPM (Fig. 7a, IP, lane  4) , apparently in a dose-dependent manner (Fig. 7a, IP,  lanes 4 and 5) . To confirm the effect of RanBPM on Zta sumoylation, plasmids expressing Flag-Zta or Flag-Rta were cotransfected with pEGFP-RanBPM to 293T cells. Results showed that although GFP-RanBPM reduced Zta sumoylation (Fig. 7b, IP, lanes 3 and 4) , levels of sumoylated Rta increased (Fig. 7b, IP, lanes 6 and 7) , demonstrating that RanBPM differentially acts upon Rta and Zta sumoylation to increase the overall transactivation activity of these two crucial immediate-early proteins. We have previously shown that RanBPM can enhance Rta sumoylation . Here, we further examined whether RanBPM influences Zta sumoylation during EBV 293T cells were cotransfected with pHARta, pFlag-Zta, and either RanBPM shRNA (shRanBPM) or control shRNA (ct-RNA). Forty-eight hours after transfection, cell lysates were immunoprecipitated by anti-Flag, and detected by IB using anti-HA. The effect of RanBPM shRNA was assessed by IB using anti-RanBPM (lanes 1-4). An asterisk indicates a non-specific protein.
lytic progression. P3HR1 cells inducted with sodium butyrate and TPA were cotranfected with pFlag-Zta, pHA-SUMO-2 and pEGFP-RanBPM. Results showed that SUMO-Zta was detectable in cells cotransfected with plasmids expressing Flag-Zta and HA-SUMO-2 (Fig. 7c , IP, lane 2), but these levels decreased with GFP-RanBPM overexpression (Fig. 7c, IP, lane 3) , indicative of an inhibitory effect on Zta sumoylation by RanBPM during lytic progression.
Influence of RanBPM-regulated sumoylation on ZRE-dependent transcriptional activation
To assess the impact on Zta transactivation activity following RanBPM inhibition of Zta sumoylation, pRp-ZRE was cotransfected with either pCMV-Zta or pCMV-Z-K12R into BJAB cells. Results showed that overexpressing Zta or Z-K12R respectively increased promoter activity by 6.9-fold and 29-fold (Fig. 7d) . Overexpression of RanBPM with either Zta or Z-K12R respectively increased promoter activity 13.9-fold and 27.5-fold (Fig. 7d) , indicating that RanBPM enhances Zta-mediated transcriptional activity, but does not affect the Z-K12R mutant. A parallel experiment was performed using the pBHLF1 reporter plasmid, and results also showed that RanBPM overexpression increased Zta-mediated promoter activity, but did not affect the Z-K12R mutant (Fig. 7d ). This suggests that RanBPM promotes Zta-mediated transcriptional activation by attenuating Zta sumoylation. Fig. 5 . Binding of the Rta-RanBPM-Zta complex on ZREs. (a) A biotin-labelled double-stranded probe containing a ZRE from the BHLF1 promoter was added to a lysate prepared from induced P3HR1 cells. A mutant mZRE probe was used as a negative control. Proteins binding to the probes were captured using streptavidin magnetic beads, and then extracted and detected by IB with anti-Rta, anti-RanBPM and anti-Zta. (b) Induced P3HR1 cells were analysed by chromatin immunoprecipitation (ChIP) assay using anti-Zta, anti-RanBPM and anti-Rta. The binding capabilities of Zta, RanBPM and Rta to the ZREs in the BHLF1, BHRF1 and BMLF1 promoters were examined by quantitative (q)PCR. Reactions were performed with and without (NC) the addition of anti-IgG as a negative control. Error bar represents SEM.
Rta-Zta synergy is dependent on promoter ZREs (Chang et al., 2010) , and this study also showed that RanBPM mediates Rta-Zta synergistic activation of viral promoters. To ascertain if RanBPM inhibition of Zta sumoylation would affect Rta-Zta synergy, we cotransfected the pRp-ZRE reporter plasmid with pCMV-R and either pCMV-Z or pCMV-Z-K12R into BJAB cells. Results showed that overexpression of Rta and either Zta or Z-K12R respectively enhanced promoter activities by 396-and 1490-fold (Fig. 7e) , as compared with control levels, and expression of RanBPM further increased promoter activities (Fig.  7e) . A similar experiment conducted with the pBHLF1 reporter plasmid also found that RanBPM overexpression increased the promoter activities of both Zta and Z-K12R (Fig. 7e) . Together, these results show that RanBPM increases Zta-dependent transactivation activity via the regulation of Zta sumoylation, but in the presence of Rta, the impact of RanBPM on Rta-Zta synergy may not be fully dependent on Zta sumoylation.
Influence of RanBPM on EBV lytic progression
To investigate the role of RanBPM on EBV lytic progression, P3HR1 cells were transfected with 0.5 mg pFlag-Zta, which is insufficient to induce lytic progression in all cells. Upon cotransfection with 5-20 mg of RanBPM, expression levels of lytic proteins, such as Rta, Zta and EA-D, subsequently increased in a dose-dependent manner (Fig. 8a, lanes 4-7) , demonstrating that RanBPM can promote EBV lytic progression. Moreover, 2089 cells were cotransfected with pFlag-Z to induce lytic activation. Expression levels of Zta, Rta, EA-D and BFRF3 were detected by immunoblotting (Fig. 8b, lane 3) . BFRF3 is a true late gene in EBV that is expressed after the activation of lytic DNA replication. Knockdown of RanBPM expression revealed that BFRF3 levels were visibly decreased (Fig. 8b, lane 4) , although slight decreases in Rta, Zta and EA-D were also detected (Fig. 8b, lane 4) . In a similar experiment that cotransfected 2089 cells with pFlag-Z-K12R, results showed that RanBPM influenced Z-K12R-mediated lytic induction (Fig. 8b, lanes  5 and 6) . These results demonstrate that RanBPM enhances EBV lytic development.
DISCUSSION
EBV employs Rta-Zta synergy to amplify signals and promote lytic progression. Our previous research indicated that this synergy depends upon the intermediary protein Luciferase activities were measured 48 h after transfection. RanBPM, Rta, Zta and a-tubulin expression were examined by IB (e). Each transfection experiment was performed three times, and each sample was prepared in duplicate. Values from each experiment were derived using the least mean square method. *P,0.05; **P,0.01. . Reduction of Zta sumoylation by RanBPM and the effect on Zta-mediated transcriptional activity. (a) 293T cells were cotransfected with pFlag-Zta, pFlag-Z-K12R, pHA-SUMO-2 or pEGFP-RanBPM. Proteins in the lysate were immunoprecipitated using anti-Flag. Proteins bound to Flag-M2 agarose beads were analysed by IB using anti-HA, anti-Flag and antiRanBPM. (b) 293T cells were cotransfected with plasmids expressing Flag-Zta, Flag-Rta, HA-SUMO-2 or GFP-RanBPM. Sumoylated proteins were immunoprecipitated using anti-Flag and detected by IB using anti-HA. (c) Induced P3HR1 cells were cotransfected with pFlag-Zta, pHA-SUMO-2 and pEGFP-RanBPM. Proteins in cell lysates were immunoprecipitated using anti-Flag, then subjected to IB using anti-HA, anti-Flag and anti-RanBPM. (d) BJAB cells were cotransfected with pRp-ZRE or pBHLF1 reporter plasmids, as well as pEGFP-RanBPM and either pCMV-Z or pCMV-Z-K12R. (e) A similar experiment was performed with the same plasmids, but with the addition of pCMV-R, to examine the effect of Rta overexpression on Rta-Zta synergy. Luciferase activities were monitored 24 h post-transfection. Each transfection experiment was performed three times, and each sample was prepared in duplicate. Values from each experiment were analysed statistically with the least mean square method. *P,0.05; **P,0.01.
MCAF1
, which simultaneously interacts with Rta and Zta to form an Rta-MCAF1-Zta complex on ZREs (Chang et al., 2010) . This study has identified another mediator, RanBPM, which recruits Rta and Zta to synergistically increase lytic transcription, indicating that EBV can hijack cellular proteins to facilitate lytic activation. Furthermore, RanBPM was found to attenuate Zta sumoylation to increase Zta-mediated transcriptional activity. Overexpression of RanBPM enhances lytic activation (Fig. 8a) , while knockdown of RanBPM expression inhibits expression levels of lytic proteins, including Rta, Zta, EA-D and BFRF3 (Fig. 8b) . These results confirm RanBPM to be a positive effector of EBV lytic development.
In vitro immunoprecipitation assays, as well as DNA affinity precipitation assays and ChIP analyses (Figs. 4 and 5), confirmed that RanBPM is also involved in Rta-Zta synergistic activation of viral promoters, and thus we sought to examine the interaction between RanBPM and MCAF1 as well. Interestingly, although RanBPM appeared to interact with MCAF1, simultaneous shRNA silencing of RanBPM and MCAF1 expression resulted in a decrease of Rta-Zta mediated activity, which was similar to the effect of silencing either RanBPM or MCAF1 alone (data not shown). This suggests that RanBPM mediates Rta-Zta synergy independently of MCAF1. Rta also interacts with Zta if the expression of RanBPM was inhibited by RanBPM shRNA, which can be attributed to the fact that MCAF1 is capable of mediating Rta-Zta interaction (data not shown). Earlier studies have shown that RanBPM is a binding partner of the TFIID subunit, TAF4 (Brunkhorst et al., 2005) , and we previously found that Rta also interacts with TAF4 to enhance Rta transactivation capability ; therefore, TAF4 may well play a role in RanBPM-mediated Rta-Zta synergy.
Previously, we found that RanBPM binds to Rta to enhance Rta sumoylation , and this study showed that RanBPM also interacts with Zta ( Fig. 1 ), but decreases Zta sumoylation (Fig. 7) . It is known that both Rta and RanBPM interact with the SUMO E2 ligase Ubc9 (Chang et al., 2004 , while Zta association with Ubc9 is quite weak (Murata et al., 2010) . This difference in affinity for Ubc9 could conceivably be utilized by RanBPM to differentially regulate Rta and Zta sumoylation status. Moreover, previous research has demonstrated that Zta sumoylation inhibits Zta-dependent transcription (Adamson & Kenney, 2001; Murata et al., 2010) , as HDAC3 preferentially associates with SUMO-Zta (Murata et al., 2010) . We found that RanBPM promotes Zta-dependent transcriptional activation (Fig. 3 ) but fails to enhance Z-K12R mediated promoter activity (Fig. 7d) , suggesting that RanBPM acts by inhibiting Zta sumoylation or promoting Zta desumoylation. It has been reported that EBV-PK can inhibit Zta sumoylation (Hagemeier et al., 2010) , while SENP1 can induce Zta desumoylation (Murata et al., 2010) , and it is possible that RanBPM may recruit these factors to participate in the regulation of Zta sumoylation. Additionally, although Z-K12R and Rta exhibited stronger synergistic activity, the fact that RanBPM overexpression further enhanced transactivation activity (Fig. 7e) indicates that the involvement of RanBPM in Rta-Zta synergy is not correlated with Zta desumoylation. It is possible that Rta sumoylation may overcome the effect of RanBPM-regulated Zta sumoylation when the Rta-RanBPM-Zta complex forms on ZREs in viral promoters, as many cellular SUMO E3 ligases, including PIAS1 and PIASx, are known to interact with Rta and enhance Rta sumoylation (Chang et al., 2004 Liu et al., 2006) . This study identified the involvement of a new mediator protein, RanBPM, in the synergistic activation of EBV viral genes by Rta and Zta during early lytic progression. RanBPM was found to bind with both Rta and Zta to form a complex at ZREs, and was shown to influence Rta and Zta sumoylation status to enhance transcriptional activity regulated by these two key viral proteins. Rta-Zta synergistic activation of key viral genes is crucial to EBV lytic progression, and here we illustrate another novel mechanism by which the virus can hijack host cellular proteins to enhance this synergy and promote viral replication.
METHODS
Cell lines and EBV lytic induction. P3HR1 and BJAB cells were cultured in RPMI 1640 medium containing 10 % FCS. 293T cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10 % FCS. 2089 cells, 293 cells stably transfected with the Maxi-EBV plasmid, p2089, were kindly provided by Dr Bill Sugden (Delecluse et al., 1998) . P3HR1 cells were treated with 3 ng TPA ml 21 and 3 mM sodium butyrate to activate the EBV lytic cycle (Davies et al., 1991; Luka et al., 1979) .
Plasmids. The GST tag expression vector, pGEX-4T1 (Amersham Biosciences) was used to construct pGEX-RanBPM (which expresses a GST-RanBPM fusion protein) according to a method described previously . pFlag-RanBPM was a kind gift provided by Dr Elisabetta Bianchi (Denti et al., 2004) . pEGFP-RanBPM (Nishitani et al., 2001 ) expresses a full-length GFP-RanBPM fusion protein, while pEGFP-RanBPM-209, pEGFP-RanBPM-334 and pEGFP-RanBPM-SPRY respectively encode aa 209-729, aa 334-729 and the SPRY domain of RanBPM . pHA-SUMO-2 was kindly provided by Dr Shih-Chung Chang. Plasmids pCMV-R, pET-Rta, pCMV-Z, pETZta and pFlag-Zta have been described previously (Chang et al., 2004 (Chang et al., , 2010 . pET-SPRY was constructed by inserting the PCR-amplified fragment into pET-32a, using primers RanBPM-684 and GST-BPM . pEGFP-Zta, pEGFP-ZN, pEGFP-ZM and pEGFP-ZC, which respectively encode the full-length, aa 1-86, aa 87-178 and aa 179-245 regions of Zta, have been described previously (Chang et al., 2010) . pFlag-Z-K12R, which substitutes lysine 12 in Zta with arginine, was constructed by inserting a PCR fragment, amplified using the primers 59-CCGGAATTCATGATGGACCCAAACTCGACTTCTGAA-GATGTAAGATTTACAC and 59-CCGGAATTCATGATGGACCCAA-ACTCG, into the Eco RI and Sal I sites in pCMV-Tag2B (Stratagene); pCMV-Z-K12R was constructed by inserting the same PCR-amplified fragment into the HindIII site of pCMV-3 (Chang et al., 2004) . The reporter plasmids pBHLF1, pEAD, pRp-ZRE and pRRE have been described previously (Chang et al., 2010) .
GST pull-down assay. GST, GST-RanBPM, and His-Zta were respectively purified from E. coli BL21(DE3)(pGEX-4T1), E. coli BL21(DE3)(pGEX-RanBPM) and E. coli BL21(DE3)(pET-Zta). GST pull-down was performed according to a method described previously (Chang et al., 2004) .
Immunoprecipitation. P3HR1 or 293T cells were washed with PBS, and cell lysates were prepared with mRIPA buffer (50 mM Tris/HCl, pH 7.8, 150 mM NaCl, 5 mM EDTA, 0.5 % Triton X-100, 0.5 % NP-40). anti-Zta antibody (1:500 dilution; Argene) or anti-RanBPM antibody (1:500; Epitomics) was added to the supernatant and incubated at 4 uC for 1 h. Protein-A/G agarose beads (30 ml) (Oncogene) were then added, and the mixture was incubated with shaking for 1 h at 4 uC, after which the beads were collected by centrifugation and washed three times with mRIPA buffer. Proteins bound to the beads were eluted with 20 ml 2| electrophoresis sample buffer, and subjected to immunoblotting with anti-Zta, anti-RanBPM (Bhende et al., 2004) , or anti-GFP antibodies (Santa Cruz Biotech). To detect sumoylated proteins, cells were harvested and washed with PBS containing 10 mM N-ethylmaleimide in 100 ml SUMO-protective buffer with 1 % SDS, then incubated at 95 uC for 10 min. The supernatant was subsequently diluted with 900 ml PBS containing 0.5 % NP-40, and incubated with the appropriate antibodies for immunoprecipitation (Chang et al., 2004; Sapetschnig et al., 2002) .
DNA affinity precipitation assay. P3HR1 cells treated with TPA and sodium butyrate were lysed in mRIPA buffer. The lysate was mixed with 300 ng 59-biotin end-labelled double-stranded probes (ZRE or mZRE) in binding buffer [60 mM KCl, 12 mM HEPES, 4 mM Tris/HCl (pH 7.9), 5 % glycerol, 0.5 mM EDTA, 1 mM DTT and 10 mg ml 21 each of leupeptin, aprotinin and 4-(2-aminoethyl)-benzenesulfonyl fluoride], and incubated with rotation for 1 h at 4 uC. Probe ZRE contained two ZRE sites from the BHLF1 promoter (59-GTCTCTGT-GTAATACTTTAAGGTTTGCTCAGGAG). Probe mZRE, which contained the same sequence as ZRE except for two mutated ZRE sites (59-GTCTCTGGTATATACTTTAAGGTTGGTATAGGAG), was used as a negative control. DNA-protein complexes were captured using 100 ml Streptavidin MagneSphere Paramagnetic particles (Promega), which were incubated with lysates for 1 h and then washed five times in binding buffer. The precipitated DNA-protein complexes were mixed in 2| electrophoresis sample buffer, and proteins were detected by immunoblotting.
Chromatin immunoprecipitation (ChIP) assay. ChIP assays were conducted as described previously (Chang & Liu, 2000) . Briefly, P3HR1 cells (1|10   7   ) were treated with TPA and sodium butyrate for 24 h to induce Rta and Zta expression. Formaldehyde was added to culture medium and incubated with shaking for 10 min to cross-link histones and DNA. After sonication, cross-linked DNA-protein complexes were immunoprecipitated using anti-Zta, anti-RanBPM or anti-Rta antibodies. The presence of specific DNA fragments in the precipitates was detected by qPCR, according to a method described previously (Chang et al., 2010) . Primers used in the amplification of the BHLF1 promoter were 59-TCGCCTTCTTTTATCCTCTTTTTG and 59-CCCAACGGGCTAAAATGACA; for the BHRF1 promoter, 59-CGCGTGCCTTACTGACTTGTC and 59-CCAGGAAGTGGCGA-GCAT; for the BMRF1 promoter, 59-GCCCGCTCACCTACATGAC and 59-GCAGCAGCAGAAGCCAAC; and for the BMLF1 promoter, 59-CCAGATGTCCCTCTATCA and 59-AACCTCTTACATCAC-TCAC. Standard curves were generated using serial dilutions of input DNA (1000, 100, 10, 1 and 0.1 %). The C t value of each reaction was quantified against the standard curve.
Transient transfection and luciferase assay. Plasmids were purified from E. coli using a plasmid purification kit (Geneaid). Transfection of BJAB and P3HR1 cells was performed by mixing 5-20 mg of plasmids and 5|10 6 cells in 300 ml culture medium. Electroporation was conducted at 975 mF and 0.2 V, using a BTX ECM630 electroporator (Harvard Apparatus). Plasmid DNA was transfected into 293T cells using Turbofect in vitro transfection reagent (Fermentas). To examine promoter activities, cells were harvested and washed with PBS, then lysed in 30 ml lysis buffer containing 25 mM Tris-phosphate (pH 7.8), 2 mM DTT, 2 mM 1,2-diaminocyclohexane-N,N,N9,N9-tetraacetic acid, 10 % glycerol, and 1 % Triton X-100. Luciferase activity was measured using an Orion II luminometer (Titertek-Berthold), according to a method described
